Qlaris Bio to Present New Data on QLS-111 for Glaucoma at World Glaucoma Congress

Qlaris Bio announced that new clinical and preclinical data on its lead investigational compound, QLS-111, will be presented at the 2025 World Glaucom...
Home/KnloSights/Clinical Trial Updates/Qlaris Bio to Present New Data on QLS-111 for Glaucoma at World Glaucoma Congress